萬星控股(08093.HK)中期溢利2053.2萬港元 同比減少18.95%
格隆匯5月11日丨萬星控股(08093.HK)公吿,截至2020年12月31日止6個月,收入1.47億港元,同比減少46.25%;期內溢利2053.2萬港元,同比減少18.95%;每股基淨利4.89港仙。
集團主要於香港及中國大陸地區為不同客户提供互聯網廣吿投放服務。2020年突如其來的COVID-19疫情爆發對全球絕大部分行業造成惡劣影響,對集團而言,互聯網廣吿業務客户均開始陸續壓縮廣吿預算,針對上述情況,集團積極做出調整,加強了對客户的篩選,優先保障優質客户的業務需求,放棄部分低毛利的客户。在2020年下半年,集團的銷售規模較去年同期減少約46.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.